CervoMed Inc. • CRVO

Capital at risk.

About CervoMed Inc.
Ticker
info
CRVO
Trading on
info
NASDAQ
ISIN
info
-
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. John J. Alam M.D.
Headquarters
info
20 Park Plaza, Boston, MA, United States, 02116
Employees
info
15
Website
info
cervomed.com
CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. Its lead drug candidate is neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, frontotemporal dementia, and ischemic stroke recovery. The company also develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$77.3M
P/E ratio
info
-
EPS
info
-$2.03
Dividend Yield
info
0.00%
Beta
info
-
Forward P/E ratio
info
0
EBIDTA
info
-
Ex dividend date
info
-
Price & volume
Market cap
info
$77.3M
Average daily volume
info
11.7M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
7.94
Price to book
info
1.97
Earnings
EPS
info
-$2.03
EPS estimate (current quarter)
info
-$0.63
EPS estimate (next quarter)
info
-$0.55
EBITDA
info
-
Revenues (TTM)
info
$9.7M
Revenues per share (TTM)
info
$1.21
Technicals
Beta
info
-
52-week High
info
$25.92
52-week Low
info
$1.80
50-day moving average
info
$2.87
200-day moving average
info
$10.74
Short ratio
info
10.62
Short %
info
16.91%
Management effectiveness
ROE (TTM)
info
69.95%
ROA (TTM)
info
42.95%
Profit margin
info
167.29%
Gross profit margin
info
$-9.1M
Operating margin
info
334.91%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
13.20%
Share stats
Outstanding Shares
info
8.3M
Float
info
5.6M
Insiders %
info
33.38%
Institutions %
info
17.22%
Analyst Insights & forecasts
info

26% Buy

62% Hold

12% Sell

Based on information from 8 analysts.

Average price target

info
$15.83
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.41
-$0.39
5.13%
Q1 • 24Beat
-$0.27
-$0.31
12.90%
Q2 • 24Beat
-$0.55
-$0.41
33.22%
Q3 • 24Beat
-$0.80
-$0.63
26.12%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-4.8M
∞%
Q3 • 24
$0M
$-6.7M
∞%
Q4 • 24
NaN%
41.07%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$48.9M
$3.2M
6.64%
Q3 • 24
$43.1M
$3.9M
9.00%
Q4 • 24
11.87%
19.50%
35.59%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-8.1M
$2.6M
$-0M
$-8.1M
Q3 • 24
$-8.1M
$9.3M
$0M
$-8.1M
Q4 • 24
0.52%
257.62%
100.00%
0.52%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a CervoMed Inc. share?
Collapse

CervoMed Inc. shares are currently traded for undefined per share.

How many shares does CervoMed Inc. have?
Collapse

CervoMed Inc. currently has 8.3M shares.

Does CervoMed Inc. pay dividends?
Collapse

No, CervoMed Inc. doesn't pay dividends.

What is CervoMed Inc. 52 week high?
Collapse

CervoMed Inc. 52 week high is $25.92.

What is CervoMed Inc. 52 week low?
Collapse

CervoMed Inc. 52 week low is $1.80.

What is the 200-day moving average of CervoMed Inc.?
Collapse

CervoMed Inc. 200-day moving average is $10.74.

Who is CervoMed Inc. CEO?
Collapse

The CEO of CervoMed Inc. is Dr. John J. Alam M.D..

How many employees CervoMed Inc. has?
Collapse

CervoMed Inc. has 15 employees.

What is the market cap of CervoMed Inc.?
Collapse

The market cap of CervoMed Inc. is $77.3M.

What is the P/E of CervoMed Inc.?
Collapse

The current P/E of CervoMed Inc. is null.

What is the EPS of CervoMed Inc.?
Collapse

The EPS of CervoMed Inc. is -$2.03.

What is the PEG Ratio of CervoMed Inc.?
Collapse

The PEG Ratio of CervoMed Inc. is null.

What do analysts say about CervoMed Inc.?
Collapse

According to the analysts CervoMed Inc. is considered a hold.